PHARMAPARK facility at bldg. 1, 8 Nauchny proezd, Moscow located in a modern 3 600 sq. m. building is used for pilot and commercial production of biopharmaceutical APIs.
The facility has premises and equipment for production of recombinant therapeutic cytokines and monoclonal antibodies. It includes upstream and downstream processing of prokaryotic and eukaryotic proteins.
Pharmstandard-UfaVITA JSC (28, Khudaiberdin street, Ufa,)
The facility is used for production of sterile liquid and freeze-dried products in ampoules, vials and prefilled syringes.